1. Home
  2. DARE vs TPCS Comparison

DARE vs TPCS Comparison

Compare DARE & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • TPCS
  • Stock Information
  • Founded
  • DARE N/A
  • TPCS 1956
  • Country
  • DARE United States
  • TPCS United States
  • Employees
  • DARE N/A
  • TPCS N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • TPCS Metal Fabrications
  • Sector
  • DARE Health Care
  • TPCS Industrials
  • Exchange
  • DARE Nasdaq
  • TPCS Nasdaq
  • Market Cap
  • DARE 31.9M
  • TPCS 32.1M
  • IPO Year
  • DARE N/A
  • TPCS N/A
  • Fundamental
  • Price
  • DARE $3.21
  • TPCS $3.10
  • Analyst Decision
  • DARE Strong Buy
  • TPCS
  • Analyst Count
  • DARE 4
  • TPCS 0
  • Target Price
  • DARE $20.33
  • TPCS N/A
  • AVG Volume (30 Days)
  • DARE 64.6K
  • TPCS 20.3K
  • Earning Date
  • DARE 11-14-2024
  • TPCS 11-12-2024
  • Dividend Yield
  • DARE N/A
  • TPCS N/A
  • EPS Growth
  • DARE N/A
  • TPCS N/A
  • EPS
  • DARE N/A
  • TPCS N/A
  • Revenue
  • DARE $1,881,316.00
  • TPCS $32,205,714.00
  • Revenue This Year
  • DARE $388.48
  • TPCS N/A
  • Revenue Next Year
  • DARE $67.37
  • TPCS N/A
  • P/E Ratio
  • DARE N/A
  • TPCS N/A
  • Revenue Growth
  • DARE 88.13
  • TPCS 1.51
  • 52 Week Low
  • DARE $3.05
  • TPCS $2.85
  • 52 Week High
  • DARE $7.56
  • TPCS $7.15
  • Technical
  • Relative Strength Index (RSI)
  • DARE 36.32
  • TPCS 36.61
  • Support Level
  • DARE $3.42
  • TPCS $2.95
  • Resistance Level
  • DARE $4.60
  • TPCS $3.49
  • Average True Range (ATR)
  • DARE 0.32
  • TPCS 0.24
  • MACD
  • DARE -0.09
  • TPCS -0.04
  • Stochastic Oscillator
  • DARE 2.11
  • TPCS 15.15

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.

Share on Social Networks: